NCT05261971View on ClinicalTrials.gov

Evaluation of the Effects of Treatments Applied to Patients With Facial Myalgia on Occlusion Parameters

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

March 24, 2020

Study Completion Date

April 12, 2020

Conditions
OcclusionQuality of Life
Interventions
DRUG

Etodolac 400 MG

Patients were asked to drink a tablet containing 400 mg of etodolac every 24 hours with a glass of water.

DRUG

Thiocolchicoside

Patients were asked to drink a tablet containing 4 mg of thiocolchicoside every 24 hours with a glass of water.

Trial Locations (1)

65080

Beyza Ünalan Değirmenci, Van

All Listed Sponsors
lead

Yuzuncu Yıl University

OTHER

NCT05261971 - Evaluation of the Effects of Treatments Applied to Patients With Facial Myalgia on Occlusion Parameters | Biotech Hunter | Biotech Hunter